ID   SRPK1_HUMAN             Reviewed;         655 AA.
AC   Q96SB4; Q12890; Q5R364; Q5R365; Q8IY12;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   05-OCT-2010, entry version 89.
DE   RecName: Full=Serine/threonine-protein kinase SRPK1;
DE            EC=2.7.11.1;
DE   AltName: Full=SFRS protein kinase 1;
DE   AltName: Full=Serine/arginine-rich protein-specific kinase 1;
DE            Short=SR-protein-specific kinase 1;
GN   Name=SRPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=94268559; PubMed=8208298; DOI=10.1038/369678a0;
RA   Gui J.F., Lane W.S., Fu X.-D.;
RT   "A serine kinase regulates intracellular localization of splicing
RT   factors in the cell cycle.";
RL   Nature 369:678-682(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH SAFB.
RC   TISSUE=Testis;
RX   MEDLINE=21523916; PubMed=11509566; DOI=10.1074/jbc.M104755200;
RA   Nikolakaki E., Kohen R., Hartmann A.M., Stamm S., Georgatsou E.,
RA   Giannakouros T.;
RT   "Cloning and characterization of an alternatively spliced form of SR
RT   protein kinase 1 that interacts specifically with scaffold attachment
RT   factor-B.";
RL   J. Biol. Chem. 276:40175-40182(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 330-345 AND 353-375, AND FUNCTION.
RX   PubMed=12134018; DOI=10.1128/JVI.76.16.8124-8137.2002;
RA   Daub H., Blencke S., Habenberger P., Kurtenbach A., Dennenmoser J.,
RA   Wissing J., Ullrich A., Cotten M.;
RT   "Identification of SRPK1 and SRPK2 as the major cellular protein
RT   kinases phosphorylating hepatitis B virus core protein.";
RL   J. Virol. 76:8124-8137(2002).
RN   [6]
RP   PROTEIN SEQUENCE OF 376-400 AND 616-636, FUNCTION, AND IDENTIFICATION
RP   IN A TOPOSOME COMPLEX.
RX   PubMed=15034300;
RA   Lee C.G., Hague L.K., Li H., Donnelly R.;
RT   "Identification of toposome, a novel multisubunit complex containing
RT   topoisomerase IIalpha.";
RL   Cell Cycle 3:638-647(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH SFRS1.
RX   MEDLINE=22946152; PubMed=14555757; DOI=10.1073/pnas.1635129100;
RA   Aubol B.E., Chakrabarti S., Ngo J., Shaffer J., Nolen B., Fu X.-D.,
RA   Ghosh G., Adams J.A.;
RT   "Processive phosphorylation of alternative splicing factor/splicing
RT   factor 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12601-12606(2003).
RN   [8]
RP   ENZYME REGULATION, PHOSPHORYLATION AT SER-51 AND SER-555, AND
RP   MUTAGENESIS OF SER-37; SER-51; SER-222; SER-311; SER-436; SER-555 AND
RP   SER-619.
RX   MEDLINE=22452801; PubMed=12565829; DOI=10.1016/S0006-291X(02)03055-3;
RA   Mylonis I., Giannakouros T.;
RT   "Protein kinase CK2 phosphorylates and activates the SR protein-
RT   specific kinase 1.";
RL   Biochem. Biophys. Res. Commun. 301:650-656(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-309 AND SER-311,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-309 AND SER-311,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-51; SER-309 AND
RP   SER-311, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   INTERACTION WITH HHV-1 ICP27 PROTEIN.
RX   PubMed=19553338; DOI=10.1128/JVI.00801-09;
RA   Souki S.K., Sandri-Goldin R.M.;
RT   "Arginine methylation of the ICP27 RGG box regulates the functional
RT   interactions of ICP27 with SRPK1 and Aly/REF during herpes simplex
RT   virus 1 infection.";
RL   J. Virol. 83:8970-8975(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-585, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 42-438 IN COMPLEX WITH ATP
RP   AND SUBSTRATE PEPTIDE, FUNCTION, AND INTERACTION WITH SFRS1.
RX   PubMed=16209947; DOI=10.1016/j.molcel.2005.08.025;
RA   Ngo J.C.K., Chakrabarti S., Ding J.-H., Velazquez-Dones A., Nolen B.,
RA   Aubol B.E., Adams J.A., Fu X.-D., Ghosh G.;
RT   "Interplay between SRPK and Clk/Sty kinases in phosphorylation of the
RT   splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.";
RL   Mol. Cell 20:77-89(2005).
CC   -!- FUNCTION: Plays a central role in the regulatory network for
CC       splicing, controlling the intranuclear distribution of splicing
CC       factors in interphase cells and the reorganization of nuclear
CC       speckles during mitosis. Hyperphosphorylates RS domain-containing
CC       proteins such as SFRS1 and SFRS2 on serine residues during
CC       metaphase but at lower levels during interphase. Locks onto SFRS1
CC       to form a stable complex and processively phosphorylates the RS
CC       domain. Appears to mediate HBV core protein phosphorylation which
CC       is a prerequisite for pregenomic RNA encapsidation into viral
CC       capsids.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Ser-51 and Ser-
CC       555.
CC   -!- SUBUNIT: Present in a seven component complex, the toposome, which
CC       separates entangled circular chromatin DNA during chromosome
CC       segregation. Interacts with HHV-1 ICP27 protein.
CC   -!- INTERACTION:
CC       Q15287:RNPS1; NbExp=1; IntAct=EBI-539478, EBI-395959;
CC       O88453:Safb (xeno); NbExp=2; IntAct=EBI-539478, EBI-539530;
CC       Q07955:SFRS1; NbExp=1; IntAct=EBI-539478, EBI-398920;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q96SB4-2; Sequence=Displayed;
CC       Name=1; Synonyms=1a;
CC         IsoId=Q96SB4-3; Sequence=VSP_035581, VSP_035582;
CC         Note=Ref.2 (CAC39299) sequence differs from that shown due to a
CC         frameshift in position 130. Isoform 1 and its properties
CC         described in PubMed:11509566 have then be considered with
CC         extreme caution. May be produced at very low levels due to a
CC         premature stop codon in the mRNA, leading to nonsense-mediated
CC         mRNA decay;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is predominantly expressed in the
CC       testis but is also present at lower levels in heart, ovary, small
CC       intestine, liver, kidney, pancreas and skeletal muscle. Isoform 1
CC       is only seen in the testis, at lower levels than isoform 2.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI20544.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI20545.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09564; AAA20530.1; -; mRNA.
DR   EMBL; AJ318054; CAC39299.1; ALT_FRAME; mRNA.
DR   EMBL; Z99128; CAI20544.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; Z99128; CAI20545.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC038292; AAH38292.1; -; mRNA.
DR   IPI; IPI00412344; -.
DR   IPI; IPI00914014; -.
DR   PIR; S45337; S45337.
DR   RefSeq; NP_003128.3; -.
DR   UniGene; Hs.443861; -.
DR   PDB; 1WAK; X-ray; 1.73 A; A=42-655.
DR   PDB; 1WBP; X-ray; 2.40 A; A=42-655.
DR   PDB; 3BEG; X-ray; 2.90 A; A=58-655.
DR   PDBsum; 1WAK; -.
DR   PDBsum; 1WBP; -.
DR   PDBsum; 3BEG; -.
DR   ProteinModelPortal; Q96SB4; -.
DR   IntAct; Q96SB4; 13.
DR   MINT; MINT-262701; -.
DR   STRING; Q96SB4; -.
DR   PhosphoSite; Q96SB4; -.
DR   PRIDE; Q96SB4; -.
DR   Ensembl; ENST00000423325; ENSP00000391069; ENSG00000096063.
DR   GeneID; 6732; -.
DR   KEGG; hsa:6732; -.
DR   CTD; 6732; -.
DR   GeneCards; GC06M035847; -.
DR   H-InvDB; HIX0005813; -.
DR   HGNC; HGNC:11305; SRPK1.
DR   HPA; HPA016431; -.
DR   MIM; 601939; gene.
DR   PharmGKB; PA36129; -.
DR   eggNOG; prNOG12521; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108512; -.
DR   OMA; HISQLQE; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 26262; -.
DR   ArrayExpress; Q96SB4; -.
DR   Bgee; Q96SB4; -.
DR   CleanEx; HS_SRPK1; -.
DR   Genevestigator; Q96SB4; -.
DR   GermOnline; ENSG00000096063; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IDA:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chromosome partition; Complete proteome; Cytoplasm; Differentiation;
KW   Direct protein sequencing; Host-virus interaction; Kinase;
KW   mRNA processing; mRNA splicing; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    655       Serine/threonine-protein kinase SRPK1.
FT                                /FTId=PRO_0000086674.
FT   DOMAIN       80    653       Protein kinase.
FT   NP_BIND      86     94       ATP.
FT   NP_BIND     166    168       ATP.
FT   ACT_SITE    213    213       Proton acceptor.
FT   BINDING     109    109       ATP.
FT   MOD_RES      37     37       Phosphoserine.
FT   MOD_RES      51     51       Phosphoserine; by CK2.
FT   MOD_RES     309    309       Phosphoserine.
FT   MOD_RES     311    311       Phosphoserine.
FT   MOD_RES     555    555       Phosphoserine; by CK2.
FT   MOD_RES     585    585       N6-acetyllysine.
FT   VAR_SEQ       5    241       VLALQARKKRTKAKKDKAQRKSETQHRGSAPHSESDLPEQE
FT                                EEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKL
FT                                GWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRL
FT                                LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL
FT                                GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI
FT                                IHTDIKPENILLSVNEQYIRRLAAEATEWQRS -> GERWS
FT                                GLRHEGQWSPGRGPGQRRELRLTAAVRFPDVRRPSTEVAPP
FT                                HTPCLWAAGPRPSFRASSGAGRSRPLFPARPARALGPLQGP
FT                                ALGGRRRPPPARPLTRPETPPAHPARALLCAPWAASPTAGR
FT                                LAEARSRPRGRPRSRAWRPCWVSTLTLVASFPPHSPFIHPS
FT                                LLQCLRSRPERKGPRPRRTKPKGNLKLSTEALLPTLRVIYQ
FT                                SRKRRFWDLMMMSKKILMIIVKEVIIL (in isoform
FT                                1).
FT                                /FTId=VSP_035581.
FT   VAR_SEQ     242    655       Missing (in isoform 1).
FT                                /FTId=VSP_035582.
FT   VARIANT      72     72       I -> T (in dbSNP:rs35519113).
FT                                /FTId=VAR_051669.
FT   MUTAGEN      37     37       S->A: No effect on protein
FT                                phosphorylation.
FT   MUTAGEN      51     51       S->A: Protein phosphorylation impaired at
FT                                this position.
FT   MUTAGEN     222    222       S->A: No effect on protein
FT                                phosphorylation.
FT   MUTAGEN     311    311       S->G: No effect on protein
FT                                phosphorylation.
FT   MUTAGEN     436    436       S->G: No effect on protein
FT                                phosphorylation.
FT   MUTAGEN     555    555       S->A: Protein phosphorylation impaired at
FT                                this position.
FT   MUTAGEN     619    619       S->A: No effect on protein
FT                                phosphorylation.
FT   CONFLICT    210    210       I -> T (in Ref. 4; AAH38292).
FT   CONFLICT    360    360       I -> L (in Ref. 5; AA sequence).
FT   CONFLICT    363    363       I -> L (in Ref. 5; AA sequence).
FT   CONFLICT    400    401       SQ -> LP (in Ref. 1; AAA20530).
FT   TURN         77     79
FT   STRAND       80     88
FT   STRAND       90     99
FT   TURN        100    103
FT   STRAND      104    111
FT   HELIX       115    133
FT   HELIX       139    143
FT   STRAND      147    155
FT   STRAND      158    165
FT   HELIX       172    178
FT   TURN        179    181
FT   HELIX       186    205
FT   HELIX       216    218
FT   STRAND      219    221
FT   HELIX       225    235
FT   HELIX       268    273
FT   STRAND      276    278
FT   HELIX       281    283
FT   HELIX       298    300
FT   HELIX       303    307
FT   HELIX       314    329
FT   STRAND      340    342
FT   HELIX       344    356
FT   HELIX       361    366
FT   HELIX       370    372
FT   STRAND      378    382
FT   HELIX       391    397
FT   HELIX       403    413
FT   HELIX       414    417
FT   HELIX       421    423
FT   HELIX       427    431
FT   HELIX       434    437
SQ   SEQUENCE   655 AA;  74325 MW;  900E980FE1C16B9A CRC64;
     MERKVLALQA RKKRTKAKKD KAQRKSETQH RGSAPHSESD LPEQEEEILG SDDDEQEDPN
     DYCKGGYHLV KIGDLFNGRY HVIRKLGWGH FSTVWLSWDI QGKKFVAMKV VKSAEHYTET
     ALDEIRLLKS VRNSDPNDPN REMVVQLLDD FKISGVNGTH ICMVFEVLGH HLLKWIIKSN
     YQGLPLPCVK KIIQQVLQGL DYLHTKCRII HTDIKPENIL LSVNEQYIRR LAAEATEWQR
     SGAPPPSGSA VSTAPQPKPA DKMSKNKKKK LKKKQKRQAE LLEKRMQEIE EMEKESGPGQ
     KRPNKQEESE SPVERPLKEN PPNKMTQEKL EESSTIGQDQ TLMERDTEGG AAEINCNGVI
     EVINYTQNSN NETLRHKEDL HNANDCDVQN LNQESSFLSS QNGDSSTSQE TDSCTPITSE
     VSDTMVCQSS STVGQSFSEQ HISQLQESIR AEIPCEDEQE QEHNGPLDNK GKSTAGNFLV
     NPLEPKNAEK LKVKIADLGN ACWVHKHFTE DIQTRQYRSL EVLIGSGYNT PADIWSTACM
     AFELATGDYL FEPHSGEEYT RDEDHIALII ELLGKVPRKL IVAGKYSKEF FTKKGDLKHI
     TKLKPWGLFE VLVEKYEWSQ EEAAGFTDFL LPMLELIPEK RATAAECLRH PWLNS
//
